Literature DB >> 19675773

EAU guidelines for management of penile cancer.

Paul K Hegarty1.   

Abstract

Entities:  

Year:  2007        PMID: 19675773      PMCID: PMC2721507          DOI: 10.4103/0970-1591.30277

Source DB:  PubMed          Journal:  Indian J Urol        ISSN: 0970-1591


× No keyword cloud information.
Dear Sir, I was impressed to see the attention the Journal[12] pays to penile cancer. We have been using the European Association of Urology (EAU) guidelines for several years. The guidelines recommend prophylactic inguinal lymphadenectomy based on the stage and grade of the primary tumor. Patients with impalpable inguinal lymph nodes are categorized into low, intermediate- and high-risk groups. Cases in the intermediate risk group with lymphovascular invasion or with growth patterns that indicate aggressive disease are offered lymphadenectomy. These categories have been based upon retrospective studies. Our recent prospective data of 100 consecutive cases has shown the value of the guidelines. Firstly, no patient in the low-risk group who had surveillance rather than inguinal node dissection, developed regional or distant metastases. Thus it is appropriate for these patients to avoid prophylactic surgery. Of the patients for whom prophylactic dissection was prescribed, only 18% had micrometastatic disease, thus 72% were overtreated. All patients who were free of nodal metastases (N0) were cured. This serves as a great psychological relief to patients as soon as the results of histopathology return. Patients with only one superficial inguinal node involved (N1) had a 100% survival, implying that lymphadenectomy is curative in these men. N2 and N3 disease had progressively poorer survival, but still many were cured by surgery alone. The risk of nodal involvement and death was predicted well by grade of the primary tumor, whereas the T stage was not helpful. Thus basing the criteria for prophylactic dissection on the current T stage is flawed and needs to be addressed. Overall the EAU guidelines are helpful as they promote curative surgery albeit exposing some patients to needless morbidity. Better prognostic indicators should help in categorizing patients in the future.
  1 in total

1.  A modified clinicopathological tumor staging system for survival prediction of patients with penile cancer.

Authors:  Zai-Shang Li; Antonio Augusto Ornellas; Christian Schwentner; Xiang Li; Alcides Chaux; Georges Netto; Arthur L Burnett; Yong Tang; JiunHung Geng; Kai Yao; Xiao-Feng Chen; Bin Wang; Hong Liao; Nan Liu; Peng Chen; Yong-Hong Lei; Qi-Wu Mi; Hui-Lan Rao; Ying-Ming Xiao; Qi-Lin Wang; Zi-Ke Qin; Zhuo-Wei Liu; Yong-Hong Li; Zi-Jun Zou; Jun-Hang Luo; Hui Li; Hui Han; Fang-Jian Zhou
Journal:  Cancer Commun (Lond)       Date:  2018-11-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.